{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:32:46Z","timestamp":1793421166950,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum f\u00fcr Infektionsforschung","doi-asserted-by":"publisher","award":["project TTU 05 . 803 \\u201CHBV Cure\\u201D"],"award-info":[{"award-number":["project TTU 05 . 803 \\u201CHBV Cure\\u201D"]}],"id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB-TRR179"],"award-info":[{"award-number":["SFB-TRR179"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["project No. 452881907"],"award-info":[{"award-number":["project No. 452881907"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["project No. 272983813"],"award-info":[{"award-number":["project No. 272983813"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB-TRR338"],"award-info":[{"award-number":["SFB-TRR338"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jhepr.2026.102033","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:27:51Z","timestamp":1789086471000},"page":"102033","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["High HBV antigen levels drive loss of vaccine-induced CD8+ T-cell function in carrier mice over time"],"prefix":"10.1016","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4604-4765","authenticated-orcid":false,"given":"Edanur","family":"Ates \u00d6z","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinpeng","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merve","family":"G\u00fcltan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3854-5288","authenticated-orcid":false,"given":"Margaret","family":"Tulessin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-9030-6411","authenticated-orcid":false,"given":"Nikolas","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7148-831X","authenticated-orcid":false,"given":"H\u00e9l\u00e8ne Anne","family":"Kerth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swati","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Mogler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7269-5433","authenticated-orcid":false,"given":"Katja","family":"Steiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4101-9280","authenticated-orcid":false,"given":"Jochen","family":"Wettengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Percy","family":"Knolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9421-1911","authenticated-orcid":false,"given":"Ulrike","family":"Protzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kosinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2026.102033_bib2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.coviro.2017.03.011","article-title":"Therapeutic vaccination for chronic hepatitis B","volume":"23","author":"Kosinska","year":"2017","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.jhepr.2026.102033_bib3","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/s41573-019-0037-0","article-title":"Therapeutic strategies for hepatitis B virus infection: towards a cure","volume":"18","author":"Fanning","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jhepr.2026.102033_bib4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nri3169","article-title":"Living in the liver: hepatic infections","volume":"12","author":"Protzer","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhepr.2026.102033_bib5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1053\/j.gastro.2018.10.032","article-title":"Targeting innate and adaptive immune responses to cure chronic HBV infection","volume":"156","author":"Gehring","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2026.102033_bib6","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1099\/vir.0.81920-0","article-title":"The immune response during hepatitis B virus infection","volume":"87","author":"Bertoletti","year":"2006","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jhepr.2026.102033_bib7","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3390\/vaccines9080841","article-title":"Immunogenicity and antiviral response of therapeutic hepatitis B vaccination in a mouse model of HBeAg-negative, persistent HBV infection","volume":"9","author":"Kosinska","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.jhepr.2026.102033_bib8","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.vaccine.2015.12.060","article-title":"Protein-prime\/modified vaccinia virus Ankara vector-boost vaccination overcomes tolerance in high-antigenemic HBV-transgenic mice","volume":"34","author":"Backes","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.jhepr.2026.102033_bib9","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jhep.2022.12.013","article-title":"Activation of CD4 T cells during prime immunization determines the success of a therapeutic hepatitis B vaccine in HBV-carrier mouse models","volume":"78","author":"Su","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.102033_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2025.102641","article-title":"MVA-HBVac\u2014a novel vaccine vector that allows pan-genotypic targeting of hepatitis B virus by therapeutic vaccination","volume":"36","author":"Kosinska","year":"2025","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.jhepr.2026.102033_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-47149-w","article-title":"Synergy of therapeutic heterologous prime-boost hepatitis B vaccination with CpG-application to improve immune control of persistent HBV infection","volume":"9","author":"Kosinska","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhepr.2026.102033_bib12","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1053\/j.gastro.2020.01.032","article-title":"Knockdown of virus antigen expression increases therapeutic vaccine efficacy in high-titer hepatitis B virus carrier mice","volume":"158","author":"Michler","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2026.102033_bib13","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3390\/biom12030470","article-title":"PD-L1 Silencing in liver using siRNAs enhances efficacy of therapeutic vaccination for chronic hepatitis B","volume":"12","author":"Bunse","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.jhepr.2026.102033_bib14","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200298","article-title":"Serum HBsAg clearance has minimal impact on CD8+ T cell responses in mouse models of HBV infection","volume":"217","author":"Fumagalli","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhepr.2026.102033_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2024.105896","article-title":"The lack of HBsAg secretion does neither facilitate induction of antiviral T cell responses nor hepatitis B virus clearance in mice","volume":"226","author":"Michler","year":"2024","journal-title":"Antivir Res"},{"key":"10.1016\/j.jhepr.2026.102033_bib16","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1053\/j.gastro.2025.02.016","article-title":"The impact of hepatitis B surface antigen reduction via small interfering RNA treatment on natural and vaccine (BRII-179)-induced hepatitis B virus-specific humoral and cellular immune responses","volume":"169","author":"Ji","year":"2025","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2026.102033_bib17","article-title":"Efficient stabilization of therapeutic hepatitis B vaccine components by amino-acid formulation maintains its potential to break immune tolerance","volume":"5","author":"Sacherl","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2026.102033_bib18","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.4049\/jimmunol.1801435","article-title":"FLEXamers: a double tag for universal generation of versatile peptide-MHC multimers","volume":"202","author":"Effenberger","year":"2019","journal-title":"J Immunol"},{"key":"10.1016\/j.jhepr.2026.102033_bib19","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/hep.1840190629","article-title":"Classification of chronic hepatitis: diagnosis, grading and staging","volume":"19","author":"Desmet","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2026.102033_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2026.1771887","article-title":"Therapeutic hepatitis B vaccine employing DNA prime\u2013MVA boost scheme requires additional priming with recombinant HBsAg to elicit an adequate antibody response","volume":"17","author":"Kerth","year":"2026","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhepr.2026.102033_bib21","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.3390\/v13081503","article-title":"Rapid and robust continuous purification of high-titer hepatitis B virus for in vitro and in vivo applications","volume":"13","author":"Wettengel","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.jhepr.2026.102033_bib22","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2413771122","article-title":"Liver-specific transgenic expression of human NTCP in rhesus macaques confers HBV susceptibility on primary hepatocytes","volume":"122","author":"Rust","year":"2025","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhepr.2026.102033_bib23","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.patbio.2009.11.001","article-title":"Pathogenesis of hepatitis B virus infection","volume":"58","author":"Chisari","year":"2010","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.jhepr.2026.102033_bib24","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1093\/infdis\/jiu281","article-title":"The chemokine receptor CXCR6 is required for the maintenance of liver memory CD8+ T cells specific for infectious pathogens","volume":"210","author":"Tse","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhepr.2026.102033_bib25","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00281-022-00932-w","article-title":"Liver-resident memory T cells: life in lockdown","volume":"44","author":"Pallett","year":"2022","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jhepr.2026.102033_bib26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40425-019-0814-7","article-title":"PD1Hi CD8+ T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma","volume":"7","author":"Ma","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.jhepr.2026.102033_bib27","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.3389\/fimmu.2019.02240","article-title":"Heterogeneity of HBV-specific CD8+ T-cell failure: implications for immunotherapy","volume":"10","author":"Heim","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhepr.2026.102033_bib28","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/s41586-024-07630-7","article-title":"A liver immune rheostat regulates CD8 T cell immunity in chronic HBV infection","volume":"631","author":"Bosch","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jhepr.2026.102033_bib29","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1016\/j.cell.2024.05.038","article-title":"Therapeutic potential of co-signaling receptor modulation in hepatitis B","volume":"187","author":"Andreata","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.jhepr.2026.102033_bib30","first-page":"893","article-title":"Phenotype and function of HBV-specific T cells is determined by the targeted epitope in addition to the stage of infection","author":"Hoogeveen","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2026.102033_bib31","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nm.4275","article-title":"Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B","volume":"23","author":"Fisicaro","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.jhepr.2026.102033_bib32","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1084\/jem.20162115","article-title":"IL-2high tissue-resident T cells in the human liver: sentinels for hepatotropic infection","volume":"214","author":"Pallett","year":"2017","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhepr.2026.102033_bib33","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1053\/j.gastro.2020.04.019","article-title":"Effects of Hepatitis B surface antigen on virus-specific and global T cells in patients with chronic hepatitis B virus infection","volume":"159","author":"Le Bert","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2026.102033_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1562107","article-title":"IL-2 and IL-15 augment HBV therapeutic vaccination and PD1 blockade for functional cure in the AAV-HBV mouse model","volume":"16","author":"Lewis","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhepr.2026.102033_bib35","article-title":"A multivalent mRNA-LNP therapeutic vaccine with broad cross-genotype immunogenicity elicits clearance of HBV infected hepatocytes","author":"Makrinos","year":"2025","journal-title":"BioRxiv"},{"key":"10.1016\/j.jhepr.2026.102033_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2025.106321","article-title":"Update on combination therapies against HBV in clinical investigations","volume":"245","author":"Mak","year":"2026","journal-title":"Antivir Res"},{"key":"10.1016\/j.jhepr.2026.102033_bib37","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00711-25","article-title":"High antigen burden drives CD8+ T cell dysfunction in a mouse model of chronic hepatitis B virus infection","volume":"99","author":"Rexhouse","year":"2025","journal-title":"J Virol"},{"key":"10.1016\/j.jhepr.2026.102033_bib38","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-019-1326-9","article-title":"TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection","volume":"571","author":"Alfei","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jhepr.2026.102033_bib39","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.jhep.2019.06.028","article-title":"Anti-PD-1 blockade with nivolumab with and without therapeutic vaccination for virally suppressed chronic hepatitis B: a pilot study","volume":"71","author":"Gane","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2026.102033_bib40","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/s41590-024-01928-4","article-title":"Attenuated effector T cells are linked to control of chronic HBV infection","volume":"25","author":"Heim","year":"2024","journal-title":"Nat Immunol"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555926003046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555926003046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:28:11Z","timestamp":1793420891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555926003046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":39,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S2589555926003046"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2026.102033","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High HBV antigen levels drive loss of vaccine-induced CD8+ T-cell function in carrier mice over time","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2026.102033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"102033"}}